Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Amino Acid Metabolism, Inborn Errors (D000592)
Parent Node:
expand
Brain Diseases, Metabolic, Inborn (D020739)
..Starting node
..expand
Tyrosinemias (D020176)

       Child Nodes:
........expandHawkinsinuria (C535845)



 Sister Nodes: 
..expand2-Hydroxyglutaricaciduria (C535306)
..expandCerebral Amyloid Angiopathy, Familial (D028243) Child2
..expandCreatine deficiency, X-linked (C535598)
..expandEncephalopathy, Spastic Tetraparesis, and Hypogonadism (C565722)
..expandEthylmalonic encephalopathy (C535737)
..expandGalactosemias (D005693)
..expandHartnup Disease (D006250)
..expandHepatolenticular Degeneration (D006527) Child2
..expandHereditary Central Nervous System Demyelinating Diseases (D020279) Child29
..expandHomocarnosinosis (C535328)
..expandHomocystinuria (D006712) Child5
..expandHyperglycinemia, Nonketotic (D020158) Child1
..expandHyperlysinemias (D020167) Child3
..expandLeigh Disease (D007888) Child12
..expandLesch-Nyhan Syndrome (D007926) Child1
..expandLysosomal Storage Diseases, Nervous System (D020140) Child70
..expandMaple Syrup Urine Disease (D008375) Child5
..expandMELAS Syndrome (D017241) Child1
..expandMenkes Kinky Hair Syndrome (D007706) Child1
..expandMERRF Syndrome (D017243)
..expandMicrophthalmia and mental deficiency (C537462)
..expandOculocerebrorenal Syndrome (D009800) Child1
..expandPeroxisomal Disorders (D018901) Child39
..expandPhenylketonurias (D010661) Child8
..expandPyruvate Carboxylase Deficiency Disease (D015324) Child1
..expandPyruvate Dehydrogenase Complex Deficiency Disease (D015325) Child4
..expandSilengo Lerone Pelizza syndrome (C537336)
..expandTricarboxylic Acid Cycle, Defect of (C564762)
..expandTyrosinemias (D020176) Child1
..expandUrea Cycle Disorders, Inborn (D056806) Child16
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:11358
Name:Tyrosinemias
Definition:A group of disorders which have in common elevations of tyrosine in the blood and urine secondary to an enzyme deficiency. Type I tyrosinemia features episodic weakness, self-mutilation, hepatic necrosis, renal tubular injury, and seizures and is caused by a deficiency of the enzyme fumarylacetoacetase. Type II tyrosinemia features INTELLECTUAL DISABILITY, painful corneal ulcers, and keratoses of the palms and plantar surfaces and is caused by a deficiency of the enzyme TYROSINE TRANSAMINASE. Type III tyrosinemia features INTELLECTUAL DISABILITY and is caused by a deficiency of the enzyme 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE. (Menkes, Textbook of Child Neurology, 5th ed, pp42-3)
Alternative IDs:OMIM:276600|OMIM:276700|OMIM:276710
ParentIDs:MESH:D000592|MESH:D020739
TreeNumbers:C10.228.140.163.100.875 |C16.320.565.100.880 |C16.320.565.189.875 |C18.452.132.100.875 |C18.452.648.100.880 |C18.452.648.189.875
Synonyms:2 Tyrosinemias, Type |2 Tyrosinemia, Type |4 Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease |4-Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease |4-Hydroxyphenylpyruvate Dioxygenase Deficiency |4 Hydroxyphenylpyruvate Dioxygenase Deficiency Disease
Slim Mappings:Genetic disease (inborn)|Metabolic disease|Nervous system disease
Reference: MedGen: D020176
MeSH: D020176
OMIM: 276600;

Genes: FAH; HPD; TAT;
Phenotypes
1 HP:0000007Autosomal recessive inheritance
2 HP:00031614-Hydroxyphenylpyruvic aciduria
3 HP:0000951Abnormality of the skin
4 HP:0001510Growth delay
5 HP:0007812Herpetiform corneal ulceration
6 HP:0003231Hypertyrosinemia
7 HP:0001249Intellectual disability
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_000353.2(TAT):c.1249C>T (p.Arg417Ter)-1-Pathogenic118203916RCV000000431; NMedGen:C0268487,OMIM:276600167160216371602163NM_000353.2:c.1249C>TNP_000344.1:p.Arg417TerNC_000016.9:g.71602163G>AOMIM Allelic Variant:613018.0003C0268487 276600 Tyrosinemia type 2
NM_000353.2(TAT):c.1085G>T (p.Gly362Val)-1-Pathogenic587776511RCV000000432; NMedGen:C0268487,OMIM:276600167160379771603797NM_000353.2:c.1085G>TNP_000344.1:p.Gly362Val16:g.71603797C>AOMIM Allelic Variant:613018.0004C0268487 276600 Tyrosinemia type 2
NM_000353.2(TAT):c.668C>G (p.Ser223Ter)-1-Pathogenic118203915RCV000000430; NMedGen:C0268487,OMIM:276600167160612771606127NM_000353.2:c.668C>GNP_000344.1:p.Ser223TerNC_000016.9:g.71606127G>COMIM Allelic Variant:613018.0002C0268487 276600 Tyrosinemia type 2
NM_000353.2(TAT):c.236-5A>G6898TATPathogenic587776512RCV000000433; NMedGen:C0268487,OMIM:276600167160993471609934NM_000353.2:c.236-5A>G16:g.71609934T>COMIM Allelic Variant:613018.0005C0268487 276600 Tyrosinemia type 2
NM_000353.2(TAT):c.169C>T (p.Arg57Ter)6898TATPathogenic118203914RCV000000429; NMedGen:C0268487,OMIM:276600167161015071610150NM_000353.2:c.169C>TNP_000344.1:p.Arg57TerNC_000016.9:g.71610150G>AOMIM Allelic Variant:613018.0001C0268487 276600 Tyrosinemia type 2